McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.
Follow MCK
McKesson Corporation (MCK) EV/FCF
As of 16 October 2026, McKesson Corporation (MCK) trades at a EV/FCF of 21.0×. Over the past ten years it has ranged from 6.5× (October 2016) to 59.2× (March 2025); the current reading is higher than 91% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2026 | 21.2× | 21.25% |
| FY2025 | 17.5× | (19.40%) |
| FY2024 | 21.7× | 72.61% |
| FY2023 | 12.6× | (12.86%) |
| FY2022 | 14.4× | 39.64% |
| FY2021 | 10.3× | 43.60% |
| FY2020 | 7.2× | (10.51%) |
| FY2019 | 8.0× | (11.81%) |
| FY2018 | 9.1× | (1.15%) |
| FY2017 | 9.2× | (31.42%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 16.2× | (23.71%) |
| Mar 2026 | 21.2× | 86.12% |
| Dec 2025 | 11.4× | (34.66%) |
| Sep 2025 | 17.4× | (3.70%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| ACH Accendra Health, Inc. compare | −11.0× |
| FOCL FocalTherics compare | −8.7× |
| COSM Cosmos Health Inc. compare | −2.3× |
| AHG Akso Health Group Sponsored ADR compare | −0.2× |
| HKPD Cellyan Biotechnology Co., Ltd compare | 5.0× |
| CAH Cardinal Health, Inc. compare | 14.0× |
| COR Cencora, Inc. compare | 18.2× |
| MCK McKesson Corporation | 21.0× |
| HSIC Henry Schein, Inc. compare | 21.2× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on MCK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement